COMMUNIQUÉS West-GlobeNewswire

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia
26/11/2024
• SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System. • Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS [...]
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market
26/11/2024
Report Highlights Nexalin’s Unique Non-Invasive Solution Addressing Deep Brain Dysfunction, Positioned to Revolutionize Mental Health Treatment HOUSTON, TX, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. ( [...]
Nelipak Healthcare Packaging Opens First North American Flexible Packaging Production Site
26/11/2024
New North Carolina Site Expands Nelipak’s Capabilities in the Americas Region CRANSTON, R.I., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading global provider of packaging solutions for [...]
Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference
26/11/2024
SEATTLE, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf cell therapies that aim to realize the full reach and promise of CAR-T cells, today [...]
Stem Cells, Superstars, And Supershow: WWE Superstar Elias Set to Face Off at WrestleCade SuperShow 2024 This Weekend
26/11/2024
WINTER PARK, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is proud to announce that this weekend, Jeff Sciullo, known in the wrestling world as Elias from WWE and business partner to ADIA [...]
Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
26/11/2024
GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer
26/11/2024
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Jeanette Fritsch Expands SIMPLY-HEALTH Platform to Offer Comprehensive Menopause Solutions for Midlife Professionals
25/11/2024
Jeanette Fritsch expands her SIMPLY-HEALTH platform, offering tailored menopause solutions for midlife professionals through her SRB&B® method. These programs target hormonal balance, enhancing vitality and [...]
Travere Therapeutics to Present at Upcoming Investor Conferences
25/11/2024
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in December: 7 th Annual [...]
Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference
25/11/2024
BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
25/11/2024
SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic [...]
Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering
25/11/2024
SAN DIEGO and TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]
Lexicon Pharmaceuticals to Participate in December Investor Conferences
25/11/2024
THE WOODLANDS, Texas, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company management, including Mike Exton, Lexicon’s chief executive officer and director, will [...]
Sana Biotechnology to Present at December 2024 Investor Conferences
25/11/2024
SEATTLE, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
25/11/2024
FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused [...]
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
25/11/2024
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished [...]
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
25/11/2024
VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
25/11/2024
OXFORD, United Kingdom and GERMANTOWN, Md., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), today announced the promotion of Geoffrey Lynn, M.D., Ph.D. to Chief [...]
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
25/11/2024
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today [...]

Pages